See alot of FLOAT talk happening well i have dug into this

New Post Public Reply Private Reply Replies (2) Message Board
wrenchman
524
See alot of FLOAT talk happening well i have dug into this a while ago and did again just now and the last SEC filing shows 181million on Sept 30 2010 》》

192901878_Screenshot_20200611-043540_SamsungInternet.jpg

Now the stock became unregistered on Nov 22 2010 and right before that there were notes issued which showed 100million shares see pic》》

418763851_Screenshot_20200611-042519_SamsungInternet.jpg

Ok so that gets us to 281mill which is what a few have posted as float after the dilutive notes right?

Now that all happened between 2010 and and 2011 and why Dalton unreg the stock but I bet not many have seen this》》


https://www.businesswire.com/news/home/201208...chase-Plan

UNIVEC announces Stock Repurchase Plan

August 06, 2012 01:47 PM Eastern Daylight Time

OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec, Inc. (OTC: UNVC) a specialty pharmaceutical company, announced that its Board of Directors have approved a stock repurchase program. Under the program management is authorized to repurchase up to 100,000,000 shares of the company's stock . The program may be limited or terminated at anytime without prior notice. Repurchase is based on profit and cash flow of the company. Under the stock repurchase program stock may be repurchased by the company from time to time in open market transaction or in privately negotiated transactions as permitted under the applicable rules and regulations.

About Univec

Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals and Transdermal products. The company is focused on diseases such as Sickle Cell Anemia, Cancer, HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Smoking Cessation and Drug addiction.

PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec promotes and pays for pharmaceutical products though its network of pharmacies. The company through it’s “StarterScript” allows in lieu of a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply of medication redeemed at any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time processing system.



So now obviously to me Dr. Dalton business recovered and he wanted to buyback the dilutive note shares.
Now ask yourselves if a buyback of 100mill announced(we don't know it ever happened of course)then how could float get to 450mill?

So my point is this last known in writing float was around 286mill and i do believe it could be a lil higher but imo not much.I say after that PR no dilution happened but again cannot say buyback happened either so draw your own conclusions!

MY OPINION IS BUYBACK COULD HAVE HAPPENED EVEN RECENTLY OR OVER YEARS AND FLOAT IS SMALL AND BROKERS COULD HAVE SOLD SHORT SHARES!

DALTONS TWEET ABOUT TOXIC ENTITIES WAS TELLING AS WELL!

MINE ARE LOCKED UP FOR A SQUEEZE TICK TOCK!

$UNVC CONGLOMERATE INC $5.00PLUS

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
info_152_photo0_67668_big.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading